Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Food Funct ; 11(6): 5525-5537, 2020 Jun 24.
Artigo em Inglês | MEDLINE | ID: mdl-32515775

RESUMO

The aim of this study is to investigate the beneficial effects of whole mung bean (WMB) and decorticated mung bean (DMB) on the regulation of serum glucose and lipid disorders in high-fat diet (HFD) and streptozotocin (STZ)-induced prediabetic mice, and to further explore their gut microbiota modulatory effects. In the present study, the ability of mung bean-based diets to combat prediabetes-related metabolic disorders was determined by assessing the changes in the physiological, biochemical, and histological parameters, and the gut microbiota composition of prediabetic mice. The supplementation of both WMB and DMB can effectively alleviate HFD and STZ-induced impaired glucose tolerance (P < 0.05), which was accompanied by improvements in pancreatic ß-cell damage and hepatic steatosis. However, only WMB supplementation significantly decreased the fasting blood glucose and fasting serum insulin levels by sensitizing insulin action (P < 0.05), and reduced the serum lipid profiles and glycosylated serum protein levels (P < 0.05). Furthermore, high-throughput pyrosequencing of the 16S rRNA gene revealed that WMB and DMB supplementation could prevent HFD and STZ-induced gut microbiota dysbiosis, especially for the enrichment of some benign bacteria, such as Bifidobacterium and Akkermansia, and the reduction of some harmful bacteria (Staphylococcus and Enterococcus). Overall, although decortication processing had an impact on the beneficial effects of mung bean, it did not cause the loss of all health benefits.


Assuntos
Dieta Hiperlipídica/efeitos adversos , Microbioma Gastrointestinal/fisiologia , Transtornos do Metabolismo dos Lipídeos/dietoterapia , Estreptozocina/efeitos adversos , Vigna , Animais , Glicemia , Diabetes Mellitus Tipo 2 , Disbiose/microbiologia , Ingestão de Alimentos , Microbioma Gastrointestinal/genética , Intolerância à Glucose , Insulina/metabolismo , Metabolismo dos Lipídeos , Lipídeos , Fígado/metabolismo , Fígado/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Estado Pré-Diabético , RNA Ribossômico 16S
2.
Nutrients ; 12(1)2020 Jan 13.
Artigo em Inglês | MEDLINE | ID: mdl-31941004

RESUMO

Menopause is clinically diagnosed as a condition when a woman has not menstruated for one year. During the menopausal transition period, there is an emergence of various lipid metabolic disorders due to hormonal changes, such as decreased levels of estrogens and increased levels of circulating androgens; these may lead to the development of metabolic syndromes including cardiovascular diseases and type 2 diabetes. Dysregulation of lipid metabolism affects the body fat mass, fat-free mass, fatty acid metabolism, and various aspects of energy metabolism, such as basal metabolic ratio, adiposity, and obesity. Moreover, menopause is also associated with alterations in the levels of various lipids circulating in the blood, such as lipoproteins, apolipoproteins, low-density lipoproteins (LDLs), high-density lipoproteins (HDL) and triacylglycerol (TG). Alterations in lipid metabolism and excessive adipose tissue play a key role in the synthesis of excess fatty acids, adipocytokines, proinflammatory cytokines, and reactive oxygen species, which cause lipid peroxidation and result in the development of insulin resistance, abdominal adiposity, and dyslipidemia. This review discusses dietary recommendations and beneficial compounds, such as vitamin D, omega-3 fatty acids, antioxidants, phytochemicals-and their food sources-to aid the management of abnormal lipid metabolism in postmenopausal women.


Assuntos
Transtornos do Metabolismo dos Lipídeos , Metabolismo dos Lipídeos/fisiologia , Menopausa/fisiologia , Pós-Menopausa/fisiologia , Adulto , Idoso , Estrogênios/deficiência , Ácidos Graxos Ômega-3 , Feminino , Humanos , Transtornos do Metabolismo dos Lipídeos/dietoterapia , Transtornos do Metabolismo dos Lipídeos/fisiopatologia , Pessoa de Meia-Idade , Obesidade , Compostos Fitoquímicos , Probióticos , Vitamina D
3.
Curr Med Chem ; 21(24): 2729-33, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24606524

RESUMO

Alterations of lipid metabolism have been increasingly recognized as a hallmark of cancer cells. Cancer cells esterify fatty acids predominantly to phospholipids, an essential component of cell membranes. The main pathway along which proliferating cells gain lipids for membrane synthesis is the endogenous mevalonate pathway. Increased synthesis of mevalonate and mevalonate-derived isoprenoids supports increased cell proliferation through activating growth-regulatory proteins and oncoproteins and promoting DNA synthesis. The importance of a better knowledge of metabolic changes in lipogenic enzymes pathways, as well as of the role of each biochemical pathway in carcinogenesis, provides the rationale for in-depth study of the oncogenic signaling important for the initiation and progression of tumors. The dependence of tumor cells on a dysregulated lipid metabolism suggests that the proteins involved in this process may be excellent chemotherapeutic targets for cancer treatment. Here, we confirm the vital link between lipogenesis and cell proliferation, and our recent findings suggest that nutritional intervention is an effective and safe way to reduce cell proliferation in experimental models of carcinogenesis. The olive oil diet significantly reduces the protein activities of lipogenic enzymes associated with cell growth. The use of natural dietary components could potentially assist in the management of subjects with metabolic disorders-related tumors.


Assuntos
Metabolismo dos Lipídeos , Neoplasias/metabolismo , Neoplasias/patologia , Animais , Proliferação de Células/efeitos dos fármacos , Gorduras Insaturadas na Dieta/administração & dosagem , Gorduras Insaturadas na Dieta/farmacologia , Gorduras Insaturadas na Dieta/uso terapêutico , Humanos , Transtornos do Metabolismo dos Lipídeos/complicações , Transtornos do Metabolismo dos Lipídeos/dietoterapia , Transtornos do Metabolismo dos Lipídeos/tratamento farmacológico , Transtornos do Metabolismo dos Lipídeos/metabolismo , Neoplasias/complicações , Neoplasias/dietoterapia , Neoplasias/tratamento farmacológico , Azeite de Oliva , Óleos de Plantas/administração & dosagem , Óleos de Plantas/farmacologia , Óleos de Plantas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA